A managed entry agreement, most associated with the UK, offering a discount to improve a treatment's cost-effectiveness enough to secure reimbursement.
HTA & Reimbursement
Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.
- Topic: HTA & Reimbursement
- 43 terms
- Editor reviewed
The specific mechanisms through which patient perspectives are formally incorporated into an assessment, including expert testimony and committee representation.
The Pharmaceutical Benefits Advisory Committee, Australia's body recommending which medicines should be subsidised under the Pharmaceutical Benefits Scheme.
A structured framework specifying the Population, Intervention, Comparator, and Outcome, used to formulate a well-defined clinical or research question.
A body's formal decision to recommend a technology for funding, based on acceptable cost-effectiveness at the reviewed price.
A formal process inviting stakeholder and public comments on a draft recommendation before it is finalised.